Fig. 1: NCAPG is overexpressed in trastuzumab-resistant breast cancer. | Cell Death & Disease

Fig. 1: NCAPG is overexpressed in trastuzumab-resistant breast cancer.

From: NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer

Fig. 1

a, b NCAPG expression was analyzed by qPCR a and western blotting b in two normal breast tissues and 12 breast cancer specimens, including seven samples of trastuzumab-resistant (TR) and five samples of trastuzumab-sensitive (TS) patients. c, d qPCR c and western blotting results d of NCAPG expression in BC tissues from patients with or without relapse. Each bar represents the mean ± SD of three independent experiments. ***P < 0.001.

Back to article page